SAMUEL SKINNER: Open Payments
NPI 1427012988 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 8 payments from 5 companies in 2025. Trend: 2023 $16 · 2024 $59 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $84 |
| Janssen Biotech, Inc. | 1 | $34 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, DUPIXENT, CREON.
Industry payments across MI — which companies pay providers there.
